Stent News: Breaking Stent News, Comments and Articles. - Page: 2

Abbott announces CE Mark for world’s longest coronary drug eluting stent

Abbott announced CE Mark in Europe for the XIENCE Xpedition™ 48 Everolimus Eluting Coronary Stent System...

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

ABBOTT PARK, Ill., May 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced CE Mark in Europe for the XIENCE Xpedition™ 48 Everolimus Eluting Coronary Stent System, the first-of-its-kind treatment for very long blockages in the vessels that supply blood to the heart due to coronary artery disease (CAD). XIENCE Xpedition 48 leverages the proven design and clinical outcomes of the...

Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets

MOUNTAIN VIEW, Calif., May 21, 2013 /PRNewswire/ -- Healthcare organizations expanding into emerging markets like Brazil, Russia, India and China (BRIC) are realizing there are no shortcuts.  This is proving particularly challenging, considering the current healthcare environment, especially in the United States.  Companies must change the dialogue around BRIC, as it is now more abo...

Evaluating a new way to open clogged arteries

Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments has drawbacks, including the risk of side effe...

Cordis Showcases Cardiovascular Innovations at EuroPCR 2013

Cordis Corporation, a global leader in innovative technology for cardiovascular interventions, will introduce the two latest additions to its portfolio of cardiovascular solutions at EuroPCR 2013, 21-24 May in Paris. EuroPCR is Europe’s largest meeting for interventional cardiovascular medicine. “We are excited to meet with our physician colle...

OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings

WIESBADEN, Germany, May 21, 2013 /PRNewswire/ -- Medical device manufacturer OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively "OrbusNeich") today announced that it has enforced the seizure of over 190 stent systems from Boston Scientific Corporation (NYSE: BSX) in connection with its patent infringement proceedings in the Dusseldorf Regional Court. The product...

Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1]

SAN DIEGO, May 21, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will demonstrate the Verrata™ Pressure Guide Wire and the iFR® (Instant wave-Free Ratio™) modality throughout the w...

Delayed Healing of Coronary Artery Following Implantation of Drug Eluting Stents, Increasing Risk of Thrombosis, is a Top Concern of Interventional Cardiologists, International Survey Shows

PARIS, May 21, 2013 /PRNewswire/ -- The delayed healing of the coronary artery following physicians' use of drug eluting stents (DES), which increases patients' risks of developing thrombosis, is a top concern today of interventional cardiologists, according to the results of a survey announced at EuroPCR 2013 in Paris. In the online survey of 141 interventional cardiologists in Belgium, Chi...

Medtronic to Honor Those Who Give Back After Receiving Life-Enhancing Medical Technology

(View the Bakken Invitation video here) Live On. Give On:  Ten inspirational people will be awarded a $20,000 charitable donation and be honored at an awards celebration in Hawaii as part of the first annual Bakken Invitation MINNEAPOLIS - May 20, 2013- Medtronic, Inc. (NYSE: MDT) announced today that applications are being accepted for the inaugural Bakken Invitation, a global program desig...

STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial

STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), announced today that the first patient was enrolled in APPOSITION V, the pivotal FDA-approved IDE trial which will enable the Company to apply for marketing approval of the Self...

Vention Medical Launches Online Tool to Speed R&D

ModCathTM to provide modular balloon catheter prototypes in as little as two weeks Vention Medical announced today the launch of an online tool that allows customers to design their own balloon catheter prototypes built to their specifications, for delivery in as little as two weeks. The new ModCathTM Online Design Tool allows users to select...

Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device

Allegheny General Hospital (AGH) in Pittsburgh has been selected to join the ABSORB III clinical trial, a multi-center international study exploring a unique bioresorbable vascular scaffold (BVS), a small mesh tube that is designed to open a blocked artery and then fully dissolve over time, leaving the vessel free of a permanent metallic implant. The FDA-approved study of the drug-eluting Absorb...

OrbusNeich's Genous™ Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients

HONG KONG, May 20, 2013 /PRNewswire/ -- OrbusNeich today announced that the company's Genous Stent is associated with a significantly lower rate of binary restenosis compared to bare metal stents (BMS) in low-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients at six months. Data from JACK-EPC, an investigator-initiated randomized study, were published in the Ju...

Absorbable Stents Take Spotlight at EuroPCR

PARIS (MedPage Today) -- Whether bioabsorbable scaffolds have anything to add to the already excellent results with metal stents will be the hot topic at this year's EuroPCR meeting here, one of the course directors said.

Erectile Dysfunction Stent Restenosis Rate Disappointing

One third of the stents used to treat erectile dysfunction were partially occluded after a year, investigators say. Medscape Medical News

Boston Scientific Presents Clinical Data at Digestive Disease Week®

NATICK, Mass., May 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in Digestive Disease Week (DDW®) 2013, May 18-21 in Orlando, Fla.  More than 24 clinical presentations will feature new data and analyses on products including the Boston Scientific SpyGlass® Direct Visualization System, WallFlex® Biliary RX Stent System and Exp...

Researchers examine new zinc-based bioabsorbable stents

In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens arteries blocked by clots or plaque deposits. After abo...

Some Hospitals Under The Microscope For Steep Pricing

The New York Times and Los Angeles Times report on specific hospitals that have been shown to be among the most expensive in the nation. Meanwhile, Modern Healthcare reports on interest from some Senators in overhauling Medicare's hospital payment system. The New York Times: New Jersey Hospital Is The Costliest In The Nation The most expensive hospital in America is not set amid the swaying...

New Emergency Stroke Treatments Can Save and Restore Lives if Patients Act Quickly and Call 911

May is National Stroke Awareness Month. Learn the symptoms and act quickly at first signs of stroke. Trenton, NJ (PRWEB) May 17, 2013 Seeking prompt emergency care at the first sign of stroke is more important than ever because new interventions can open clots and restore blood flow to the brain, often reducing or preventing permanent damage. A new generation of mechanical blood clot retrieval de...

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

NATICK, Mass., May 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate at the annual EuroPCR Scientific Program May 21-24 in Paris. "We are pleased to present a particularly rich and diversified set of data this year at EuroPCR," said Keith Dawkins, M.D., global chief medical officer, Boston Scientific.  "The primary endpoint results for several...

Direct Flow Medical® Receives IDE Approval for U.S. SALUS Trial of Transcatheter Aortic Heart Valve System

Direct Flow Medical®, Inc., a transcatheter heart valve company focused on improving patient outcomes, today announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the SALUS feasibility trial of the Direct Flow Medical Transcatheter Aortic Heart Valve...

InspireMD to Announce Six-Month Results from the MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR

BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ --  -Strong Conference Presence to Include Presentations/Educational Events Featuring the MGuard™ Embolic Protection Stent-  - Company to Host Conference Call on Thursday, May 23rd to Review MASTER Data - InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), the leader in embolic protection stents, today anno...

The Accreditation for Cardiovascular Excellence (ACE) Presents Accreditation Quality Improvement Data at SCAI Scientific Sessions

Quality Data Metrics Confirm the Value of ACE Accreditation and E3: More than Peer Review Services Orlando, FL (PRWEB) May 16, 2013 Data showing improved quality results for cardiac cath labs that apply for accreditation through the Accreditation for Cardiovascular Excellence (ACE) were presented during the SCAI Scientific Sessions in Orlando, FL, May 8-10, 2013. The study is the first of its kin...

Tryton Medical Announces CE Mark and European Launch of Next-Generation Tryton Side Branch SHORT Stent

New Stent Will Be Featured at EuroPCR 2013 Exhibit Booth #M27 May 21-24 in Paris Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced that the company received the CE Mark for the Tryton Side Branch SHORT Stent, a novel coronary stent system that broadens the treatment options in bifurcations in l...

St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement

Next-generation system provides a real-time 360-degree panoramic view of the arteries in 3-D St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of its ILUMIEN™ OPTIS™ PCI Optimization System™, a new technology designed to provide physicians with a comprehensive disease assessment tool for t...